Extracts prepared from tissue with granulomatous inflammation experimentally produced in liver of CBA-strain mice showed increased hydrolysis of leukotriene D4 (LTD4), Leu-Leu and Ala-Gly as compared with normal hepatic cells. Two dipeptidases, Leu-Leu dipeptidase and Ala-Gly dipeptidase, were purified from hepatic granulomas, and quantitative conversion of LTD4 into leukotriene E4 (LTE4) by both enzymes was demonstrated. Mr values of the purified enzymes were 178 000 for Leu-Leu dipeptidase and 183 000 for Ala-Gly dipeptidase. The enzymes showed homogeneity, appearing as a single band on SDS/PAGE, and the Mr values of the subunits were 56000 and 57000 for Leu-Leu and Ala-Gly dipeptidase respectively. The amino acid compositions of the two enzymes differed considerably from each other. The activity of Leu-Leu dipeptidase was inhibited by bestatin and captopril and stabilized with MnCl2. The Km for LTD4 was 25 /uM with a Vmax. of 49.0 4umol/min per mg. In contrast, the activity of Ala-Gly dipeptidase was inhibited by cilastatin, cytinylglycine, EDTA and dithiothreitol, and also by captopril. The Km for LTD4 was 5.3 /aM with a Vm.ax of 50.4 umol/min per mg. The findings indicate that the conversion of LTD4 into LTE4 by microsomal dipeptidases is elevated during granulomatous tissue reaction. This enzyme activity may become useful for biochemical quantification of the pathological tissue reaction that occurs in organized granulomas.
INTRODUCTION
Leukotriene D4 [slow-reacting substance (SRS)-Cys-Gly; LTD4], a highly bioactive component of slow-reacting substance, is known to be transformed into the less active leukotriene E4 (SRS-Cys; LTE4). The reaction has been shown to be catalysed by peptidases such as microsomal alanine aminopeptidase (Sok et al., 1980) , lysosomal arginine aminopeptidase (Yokota et al., 1983) and microsomal dipeptidase (Kozak & Tate, 1982) . Since increases in leukotriene concentration are reported to be associated with up-regulation of inflammatory conditions, including granulomatous tissue reactions (Brain et al., 1984a, b; Chensue et al., 1985) , and leukotriene C4 and LTD4 have been shown to be mitogens (Morelli et al., 1989) , we questioned whether conversion of LTD4 into LTE4 is also associated with granulomatous tissue reaction. In order to investigate this possibility, we measured conversion of LTD4 into LTE4 as well as microsomal dipeptidase activity in crude extracts of mouse skin at different times after granulomatous tissue reaction elicited by inoculation of a granulomatous stimulus by the method of Okamoto et al. (1987) . An increase in dipeptidase activity, analysed by measuring hydrolysis of Leu-Leu and Ala-Gly, corresponded to the time course of the inflammatory process, and formation of LTE4 from LTD4 by the skin granuloma tissue extract was detected (Sato et al., 1991) . Furthermore, the LeuLeu and Ala-Gly dipeptidases detected in the granulomatous tissue reaction showed different inhibitor profiles, suggesting the possibility that at least two dipeptidases may function simultaneously in this pathological condition. Purification and characterization of these dipeptidases were, however, not possible from the skin granulomatous inflammation, because of limited amounts of tissue.
Hypersensitive granulomas develop in liver of mice infected with Schistosoma mansoni (Hsu et al., 1972; Epstein et al., 1979) . In this study we report purification and characterization of two dipeptidases that preferentially hydrolyse Leu-Leu or Ala-Gly from hepatic granulomas. Both dipeptidases formed LTE4 from LTD4 in a quantitative manner. Inhibition profiles of the two purified dipeptidases from hepatic granulomas showed a trend similar to those of the crude enzymes from skin granulomas, confirming that the specific dipeptidase activities are associated with granulomatous inflammation. Although Leu-Leu and AlaGly dipeptidases differ from each other in enzymic properties, both dipeptidases appear to belong to the class of microsomal dipeptidases.
EXPERIMENTAL

Materials
Female CBA-strain mice (5-6 weeks old) were purchased from Jackson Laboratories (Bar Harbor, ME, U.S.A.). Q-Sepharose Fast Flow, Sephacryl S-300 superfine and concanavalin A (Con A)-Sepharose were obtained from Pharmacia Biotechnology Inc. (Piscataway, NJ, U.S.A.). LTD4, Leu-Leu and Ala-Gly were from Sigma Chemical Co. (St. Louis, MO, U.S.A.)
Hepatic granulomas
Mice were injected subcutaneously with 75 cercariae of the Puerto Rican strain of Schistosoma mansoni. They were killed and the livers were removed 9 weeks later. The granuloma-rich fraction was separated from hepatic cells by the method of Nishimura et al. (1985) . The granulomas were pooled, quickly frozen in liquid nitrogen and stored at -70 'C. Livers from agematched non-infected mice also were stored at -70 'C for extraction of normal liver enzymes.
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Enzyme assays Leu-Leu hydrolysis was measured by the method of Sugiura et al. (1978) . The standard assay mixture contained 4 ,amol of LeuLeu in 1 ml of colour reagent in which 8 mg of 4-aminoantipyrine, 20,u of NN-dimethylaniline and 300 units of peroxidase were dissolved in 100 ml of 150 mM-Tris/HCl, pH 8.0, and 0.1 ml of enzyme solution. The reaction was carried out at 37°C for 20 min and stopped by the addition of 1 ml of 0.1 M-acetic acid. The absorbance was measured at 550 nm. One unit of dipeptidase activity is defined as 1 #tmol of Leu-Leu hydrolysed/min at 37°C. Ala-Gly dipeptidase was measured by the ninhydrin method (Kozak & Tate, 1982) . A reaction mixture of 0.5 ml consisting of 50 mM-Tris/HCl buffer, pH 8.0, enzyme solution and 0.4 mmAla-Gly was incubated at 37°C for 10-20 min. The reaction was stopped by addition of 0.25 ml of 1 M-acetate buffer pH 5.3. Amino acid release from the substrate was determined by the ninhydrin method. One unit of Ala-Gly dipeptidase activity was defined as the amount needed to liberate 1 ,umol of amino acid from the substrate/min at 37 'C. The standard assay for other dipeptides and tripeptides was performed in the same way. The catalytic activity of the enzymes on amino acid-,/-naphthylamide derivatives was measured by the method of Ito et al. (1984) . One unit of enzyme activity was defined as that which hydrolysed I ,tmol of substrate/min. Protein was determined by the method of Lowry et al. (1951) using BSA as a standard.
H.p.l.c. assay of conversion of LTD4 into LTE4
The method described by Campbell et al. (1990) was used. The reaction mixture of 100 ,al, consisting of 50 mM-Tris/HCl buffer (pH 8.0), sample solution and 5 uM-LTD4, was incubated at 37°C for 5 min. The reaction was stopped by addition of 5 ,ul of 0.5 % (v/v) acetic acid, and the mixture was stored on ice. Samples (20 ,l) were injected manually into a C18 reversed-phase column (Nucleosil C18 5 m 4.2 ml bed vol.; Alltech, Deersfield, IL, U.S.A.) with a Hamilton no. 702 sample injector. The column was eluted isocratically with methanol/water/acetic acid (69: 31: 1, by vol.) which had been adjusted to pH 5.7 with NH3. The flow rate was 1.0 ml/min, and the leukotrienes were detected with a u.v. spectrophotometric detector (Shimadzu SPD-6AV) at 280 nm. One unit of dipeptidase activity was defined as the amount of enzyme that hydrolysed I pmol of LTD4/min.
Purification of dipeptidases from hepatic granulomas
A crude extract of 3 g of isolated hepatic granulomas after 9 weeks infection was homogenized in a mixture of water and butan-I -ol with proportions of tissue/water/butan-I -ol of 1: 3: 1 (w/v/v) (1 weight/3 vol/l vol) and centrifuged at 10000g for 10 min. Proteins in the supernatant were precipitated with 60 % acetone at 0°C and dissolved in 50 mM-Tris/HC1, pH 8.0, containing 0.1 mM-MnCl2. The enzymes were precipitated between 40 and 60 %-satd. (NH4)2SO4 and dialysed against 10 litres of 50 mmTris/HCl, pH 8.0, containing 0.1 mM-MnCl2 for 20 h at 4°C. These proteins were applied to a Q-Sepharose Fast Flow column (38 ml bed vol.) equilibrated with 50 mM-Tris/HCl buffer (pH 8.0) containing 0.1 mM-MnCl2. After the column had been washed with 50 ml of the same buffer, the enzymes were eluted with a linear concentration gradient from 0 to 0.3 M-NaCl. Hydrolysis of Leu-Leu and Ala-Gly was detected in separate fractions. Each active fraction was concentrated through a membrane filter (Amicon XM-50) and adjusted to 1.5 nm with 50 nIM-Tris/HCl, pH 8.0, containing 0.1 mM-MnCl2 and 50 mmNaCl. They were applied to a Sephacryl S-300 column (160 ml bed vol.) equilibrated with 50 mM-Tris/HCI, pH 8.0, containing 0.1 mM-MnCI2 and 50 mM-NaCl. The enzyme fractions were again separately concentrated through the membrane filter, and applied to a Con A-Sepharose column (5 ml bed vol.) equilibrated with 50 mM-Tris/HCI, pH 8.0, containing 0.1 mmMnCl2. Leu-Leu dipeptidase was not absorbed and appeared in the eluate, whereas Ala-Gly dipeptidase was absorbed on the column and collected by washing with the same buffer containing 20 mg of methyl a-glucoside/ml. The dipeptidases were further purified by h.p.l.c. (Bio-Rad Bio-Sil SEC-250 columns; 27 ml bed vol.) equilibrated with 50 mM-Tris/HCl, pH 8.0, containing 0.1 mM-MnCl2 and 200 mM-NaCl, and used as a purified enzyme.
SDS/PAGE
The method of Laemmli (1970) was used with 12.5 % (w/v) polyacrylamide and a constant current of 20 mA per slab gel. Proteins were detected with Coomassie Brilliant Blue R-250.
Amino acid composition analysis
The proteins for amino acid analysis were prepared by the method of Ploug et al. (1989) . SDS/PAGE of purified enzymes was performed. The proteins were transblotted on a poly-(vinylidene difluoride) (PVDF) membrane. A single band corresponding to each enzyme was cut from the PVDF membrane, and amino acid composition analysis was carried out at the Protein and Nucleic Acid Facility, Beckman Center, Stanford University Medical Center (Stanford, CA, U.S.A.).
RESULTS AND DISCUSSION Purification of dipeptidases from hepatic granulomas
The hydrolysis of Leu-Leu, Ala-Gly and LTD4 by crude extracts prepared from hepatic granulomas developed 9 weeks after infection with Schistosoma mansoni was compared with that by normal liver crude extract (Table 1) ; it was increased 4.9-, 3.2-and 3.2-fold respectively. Campbell et al. (1990) reported timedependent release of dipeptidase from lung membrane preparations, by digestion with phosphatidylinositol-specific phospholipase C purified from Bacillus thuringiensis. In a separate experiment we tried to extract the enzyme, using phospholipase C. The membrane preparation was collected and incubated with phospholipase C (0.05 unit/ml) at 37 'C for 1 h, but recovery of dipeptidase activity from the granulomatous tissues was extremely low as compared with the activity of the enzymes extracted by the method of Ito et al. (1983) using butan-1-ol treatment as in this study.
The methodology used for purification of the enzymes was essentially as described by Sugiura et al. (1978) for human kidney, although DEAE-cellulose chromatography was replaced by Q-Sepharose Fast Flow column chromatography, which readily separated Leu-Leu and Ala-Gly dipeptidase activities (Fig. 1 ). The two dipeptidases were then separately purified by Sephacryl S-300 column chromatography followed by ConA- The protein fractionated with (NH4)2SO4 was dialysed and applied to a column as detailed in the Experimental section. Bound proteins were eluted with a linear gradient of 0-0.3 M-NaCl ( ----), and 3.3 ml fractions collected and assayed for hydrolysis of Leu-Leu (0) and Ala-Gly (0). Sepharose chromatography. Ala-Gly dipeptidase bound to Con A-Sepharose, whereas Leu-Leu dipeptidase did not. Kidney dipeptidases from human (Sugiura et al., 1978) and pig (Littlewood et al., 1989) with enzyme properties similar to the Ala-Gly dipeptidase from granulomas were shown to be glycoproteins. Final purification of the dipeptidases was accomplished by h.p.l.c., and recovery of protein and purification yield of the purified enzymes were calculated ( Table 2 ). The Mr of Leu-Leu dipeptidase was 178000 and that of Ala-Gly dipeptidase was 183000.
Substrate specificity
The catalytic activities of the two dipeptidases with various synthetic substrates are compared in Table 3 . The most reactive substrates for Leu-Leu dipeptidase and Ala-Gly dipeptidase were Leu-Leu and Ala-Gly respectively. The rate of hydrolysis of other dipeptides was much lower, except for Leu-Leu dipeptidase on His-Leu and Ala-Gly dipeptidase on Ala-Ala. In addition, Leu-Gly was hydrolysed moderately efficiently by both enzymes. The granuloma enzymes did not hydrolyse ,-naphthylamide Vol. 284 aminopeptidase substrates, but showed hydrolytic activity for some tripeptides tested in this study. The hydrolytic activity of the two granuloma enzymes with different dipeptide substrates was further contrasted with substrate specificity reported for others from various tissues. Hepatic granuloma Leu-Leu dipeptidase activity is similar to human liver dipeptidase activity (Sugiura et al., 1977; Ito et al., 1987) , but Ala-Gly dipeptidase activity appears to be more like the activity reported for kidney dipeptidase from hog (Campbell et al., 1966; Harper et al., 1971) , human (Sugiura et al., 1978; Ito et al., 1987) and rat (Kozak & Tate, 1982) . The kinetic constants (Table 4) of purified granuloma enzymes towards the most reactive substrates were examined by Lineweaver-Burk plots as well as by an analysis program for the microcomputer (Yamaoka et al., 1981) , by using substrate concentrations of 0.1-0.5 mm in 50 mM-Tris/HCI buffer, pH 8.0, at 37 'C. keat/Km (uM-1 * -1) was calculated to be 0.13 for LeuLeu dipeptidase and 0.27 for Ala-Gly dipeptidase with Leu-Leu and Ala-Gly respectively as substrates. Kinetic data for comparison from previous studies are quite limited Sugiura et al. (1977) , but the values for hydrolysis of Ala-Gly by the granuloma enzyme and rat kidney enzyme (Kozak & Tate, 1982) were comparable at Km 0.8 mm.
The conversion of LTD4 into LTE4 catalysed by Ala-Gly dipeptidase detected by h.p.l.c. is illustrated in Fig. 2 . A decrease in the LTD4 peak was associated with the appearance of an LTE4 peak, but no other peak was detectable at 280 nm, indicating specificity for the enzyme reaction. The retention times measured were 21.6 min for LTD4 and 25.7 min for LTE4. Conversion of LTD4 into LTE4 by dipeptidases from various tissue has been reported without kinetic values by Kozak & Tate (1982 ), Hirota et al. (1985 , 1986 ) and Campbell et al. (1988 . Table 4 lower than sheep lung dipeptidase (Km = 43.6 um; Campbell et al., 1990) , comparable with that of hepatoma cells (Km = 6.6 pum; Huber & Keppler, 1987) , but considerably higher than that reported for the enzyme from human polymorphonuclear leucocytes (Km = 0.95 ,uM; Raulf et al., 1987) .
Effects of bivalent cations
The percentage residual activity of the two dipeptidases after preincubation with a final concentration of 1 mm of each bivalent cation at 37°C was calculated, taking the activity without additions as 100 %. A modest activation of Leu-Leu dipeptidase with MnCl2 (117 %) and Ala-Gly dipeptidase with ZnCl2 (114%) was found. MnCl2 activation has also been reported for human liver (Sugiura et al., 1977) and pancreatic (Ito et al., 1983) enzymes, both of which effectively hydrolyse Leu-Leu. The rate of MnCl2 activation of the granuloma enzyme was much lower than that seen for the human enzymes. However, MnCl2 seems to have a 'stabilizing' effect on the granuloma Leu-Leu dipeptidase, as the enzyme activity was rapidly lost during the first and second steps of purification without 0.1 mM-MnCl2 in the buffers. Whether ZnCl2 is an activator ofAla-Gly dipeptidases from other tissue sources is unknown, although hog kidney (Campbell et al., 1966) and rat kidney (Kozak & Tate, 1982) enzymes are reported to contain zinc. FeCl2 inhibited Leu-Leu Patterson, 1989) , but a non-competitive inhibitor of human kidney enzyme (Ki 4.25 sum; Campbell et al., 1988) . It was found not to inhibit hydrolysis of glycyldehydrophenylalanine by rat kidney and lung dipeptidase (Hirota et al., 1985 (Hirota et al., , 1986 ), but Littlewood et al. (1989) reported inhibition of hydrolysis of the same substrate by the hog kidney enzyme. Bestatin also did not inhibit hydrolysis of LTD4 by human polymorphonuclear leucocytes (Raulf et al., 1987) . Although the precise inhibitory mechanisms of the different enzymes remain to be determined, this inhibitor most clearly differentiates between the two dipeptidases associated with granulomatous inflammation. The effects of Cys-Gly, an inhibitor of the rat kidney enzyme (Kozak & Tate, 1982) , were contradictory as it was a much stronger inhibitor of Ala-Gly dipeptidase than of Leu-Leu dipeptidase. The inhibitory activity of cilastatin toward dipeptidase is well established (Koller et al., 1985; Hirota et al., 1985 Hirota et al., , 1986 Littlewood et al., 1989) . It showed a modest inhibition of both granuloma dipeptidases but was more effective with Ala-Gly dipeptidase. Chelators such as o-phenanthroline and EDTA showed inhibitory activity toward Ala-Gly dipeptidase, as also reported for human and hog enzymes (Harper et al., 1971; Sugiura et al., 1977 Sugiura et al., , 1978 , but did not inhibit Leu-Leu dipeptidase. Similarly dithiothreitol inhibited Ala-Gly dipeptidase but not Leu-Leu dipeptidase.
Captopril is an inhibitor of angiotensin-converting enzyme (Ondetti et al., 1977) . Ito et al. (1987) peptidases respectively. SDS/PAGE of both enzymes (Fig. 3) showed apparent homogeneity and the Mr of the subunits of Leu-Leu dipeptidase was calculated to be about 56000 and that of Ala-Gly dipeptidase about 57000. Most dipeptidases from mammalian tissues have been reported to have Mr values higher than 100000 and to be composed of subunits ranging in Mr from 45000 to 100000 (Hooper et al., 1990; Hirota et al., 1985; Sugiura et al., 1978) .
Amino acid composition
Amino acid analysis ( differences between the compositions of Leu-Leu and Ala-Gly dipeptidases were observed. Leu-Leu dipeptidase contained a higher percentage of threonine and serine and a lower percentage of leucine.
Role of leukotrienes in granulomatous inflammation Leukotrienes, derived via the lipoxygenase pathway from arachidonic acid, are pro-inflammatory peptidolipids which have been implicated in the pathobiology of a number of human diseases, particularly hypersensitivity (Lewis et al., 1990) . Their place in chronic granulomatous inflammation, however, is less clear. In the few studies that have addressed the question, alveolar macrophages from patients with sarcoidosis (Bachwich et al., 1987) or during experimental pulmonary granuloma formation (Shellito & Smezek, 1990) and macrophages from patients with hepatic schistosomiasis (Tripp et al., 1988) produced decreased or normal amounts of the leukotrienes measured and increased amounts of other eicosanoids. Since no-one has assayed the full complement of leukotrienes or done a complete timecourse analysis, the conclusion that leukotriene metabolism in granulomas is depressed may be premature. This cautionary note is especially cogent because macrophages possess leukotrienemetabolizing enzymes and their activity is higher than that found in neutrophils or lymphocytes (Nagaoka & Yamashita, 1987a,b) . Furthermore our findings of a marked elevation of LTD4-metabolizing activity in both skin (Sato et al., 1991) and liver granulomas suggest the opposite may be true. It may be possible that, during granulomatous inflammation, eicosanoid metabolism through the leukotriene pathway is elevated but accelerated to its terminus in a down-modulating mode which might be important for maintaining lesional homoeostasis and chronicity. Alternatively, the dipeptidases studied by us may have other natural substrates in the granulomatous tissue. A more thorough analysis of the leukotriene pathway is required to resolve this issue. In the meantime, it is clear that LTD4-metabolizing dipeptidase activity closely follows the course of development of experimental hypersensitivity granulomas in skin, and as such is a candidate to become a useful marker of granulomatous inflammation in the same way as angiotensin-converting enzyme and proline endopeptidase (lida et al., 1991) . This study was supported by the National Institutes of Health grant no. AR31853.
